Findings

What do systematic reviews say?

26 questions · 26 findings · 4 reviews · Headline outcomes only

No studies found 6 · 23.1%GRADE not reported 0 · 0%Very low 0 · 0%Low 11 · 42.3%Moderate 8 · 30.8%High 1 · 3.8%

5‐year disease specific survival rate (5 to 15 yr) · women with locally advanced uterine cervix cancer

The intervention showed no clear difference in 5‐year disease specific survival rate (5 to 15 yr) (moderate certainty).

1 finding from 1 review

10‐year disease specific survival rate (5 to 15 yr) · women with locally advanced uterine cervix cancer

The intervention showed no clear difference in 10‐year disease specific survival rate (5 to 15 yr) (moderate certainty).

1 finding from 1 review

3‐year relapse‐free survive rate (37.2/40.2 mo) · women with locally advanced uterine cervix cancer

The intervention showed no clear difference in 3‐year relapse‐free survive rate (37.2/40.2 mo) (low certainty).

1 finding from 1 review

5‐year relapse‐free survive rate (66 mo) · women with locally advanced uterine cervix cancer

The intervention showed no clear difference in 5‐year relapse‐free survive rate (66 mo) (low certainty).

1 finding from 1 review

3‐year local control rate (37.2/40.2 mo) · women with locally advanced uterine cervix cancer

The intervention showed no clear difference in 3‐year local control rate (37.2/40.2 mo) (low certainty).

1 finding from 1 review

5‐year local control rate (3 to 6 yr) · women with locally advanced uterine cervix cancer

The intervention showed no clear difference in 5‐year local control rate (3 to 6 yr) (low certainty).

1 finding from 1 review